Addus Projects ‘Strong, Steady’ Hospice Growth Amid Lingering Pandemic Census Headwinds

In case you missed it, Hospice News has launched a new specialty publication for palliative care professionals. You can subscribe to Palliative Care News here: Subscribe today! Addus HomeCare Corp. (NASDAQ: ADUS) saw hospice growth in 2023, despite lingering pandemic-related challenges around daily census. The company anticipates growth in its personal care business in 2024, which will […]

Addus HomeCare to Accelerate Acquisition Activity

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. (NASDAQ: ADUS) remains on the hunt. The most prominent home-based care transactions so far this year have involved payers seeking to acquire large providers with multiple business lines. Addus has been among the few publicly traded companies that have […]

Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority. But this […]

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. Like many hospice providers, Addus has faced COVID-19 challenges that include reduced patient volumes and shorter length of […]

3 Palliative Care Providers to Watch

As the demand for palliative care continues to grow, so too has the way businesses have bolstered their programs to better serve patients. Providers are consistently looking for new methods to deliver responsive, value-based services that can generate savings and reduce high-acuity utilization. Hospice News spoke with three palliative care providers that have risen to […]

High Price Tags Pushing Addus Away from Hospice Acquisitions

High valuations have led Addus HomeCare (NASDAQ: ADUS) to pivot towards personal care and home health deals rather than hospice acquisitions. Hospice multiples broke records in 2020, 2021 and 2022, reaching as high as 29x. And though last year’s numbers were somewhat skewed by massive deals, price tags remain high overall. Those costs are making […]

Addus Expects ‘Bit of Bumpiness’ in Hospice, Looks to Further Grow Home Health Business

Staffing improvements and reimbursement shifts are paving Addus HomeCare’s (NASDAQ: ADUS) growth path this year. That path will divert more toward home health and personal care – and less in the direction of hospice – as 2023 progresses. Addus’ more than 33,000 employees serve around 46,500 patients across roughly 200 locations nationwide. The company added […]

Hospice News’ Top 10 Stories of 2022

In 2022, the hospice community laid the groundwork for a transformational 2023. This year saw industry-changing acquisitions, some of the worst labor headwinds to date, the return of sequestration and a sometimes volatile national economy. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice […]

5 Game-Changing Hospice Deals from 2022

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. Optum to pick up LHC Group Though […]

As Headwinds Rage, Large Hospice Companies Lay Groundwork for Potential 2023 Growth

Labor shortages and other headwinds have battered hospices during 2022, including large companies. Some of these providers are making near-term investments that cut into revenue but are expected to pay off in the long run. Providers are seeing troubles on multiple fronts, as reflected in third quarter earnings reports. This year brought the return of […]